2526 — Hangzhou Diagens Biotechnology Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$20.80bn
- HK$20.75bn
- CNY164.42m
Annual balance sheet for Hangzhou Diagens Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 84.5 | 58.6 | 45.5 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 15.3 | 36.3 | 54.5 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 131 | 122 | 136 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 35 | 37.2 | 29.3 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 221 | 212 | 216 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 23.7 | 31.9 | 45.2 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Minority Interest | |||
| Total Liabilities | 307 | 38.3 | 49.9 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Unrealized Gain / Loss | |||
| Total Equity | -85.6 | 174 | 166 |
| Total Liabilities & Shareholders' Equity | 221 | 212 | 216 |
| Total Common Shares Outstanding |